Beijing Sinotau International Pharmaceutical Technology Co., Ltd.
PrivateLast Round
Growth Equity
Dec 1, 2024
Est. Valuation
$716.4M
Total Funding Raised
$415.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. is a radiopharmaceutical company that develops and commercializes diagnostic and therapeutic radiopharmaceuticals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Comparables
Compare Beijing Sinotau International Pharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yantai Lannacheng Biotechnology Co., Ltd. | 77% | |
| Hangzhou Eli Radiopharma Co., Ltd. | 77% | |
| Chengdu NewRT Medical Technology | 77% |
For institutional investors. Book with your work email.
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Dec 1, 2024 | ||||
| Series E | Jul 3, 2023 | ||||
| Series D Extension | Oct 21, 2021 | ||||
| Series D | Feb 23, 2021 | ||||
| Series C | Jul 1, 2020 | ||||
Series B | Jun 1, 2017 |
For institutional investors. Book with your work email.
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GF Qianhe Investment | Series E |
| Centurium Capital | Series D Extension |
| 中信金石投资有限公司 | Series E |
| Guoke Jiahe Capital | Series C |
| 健壹资本 | Series C |
| SDIC Chuangyi Industrial Fund Management | Series E |
| Guangdong Technology Financial Group | Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 850% MoM, from 96 to 912.
- Feb 1, 2026
Monthly visitors increased 75% MoM.
For institutional investors. Book with your work email.
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing Sinotau International Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Sinotau International Pharmaceutical Technology Co., Ltd. a public or private company?
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. is a private company.
What is the current stock price of Beijing Sinotau International Pharmaceutical Technology Co., Ltd.?
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Sinotau International Pharmaceutical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing Sinotau International Pharmaceutical Technology Co., Ltd. worth (valuation)?
Beijing Sinotau International Pharmaceutical Technology Co., Ltd.'s valuation is estimated at $716.4M based on funding round data.
Can I buy Beijing Sinotau International Pharmaceutical Technology Co., Ltd. stock?
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing Sinotau International Pharmaceutical Technology Co., Ltd.'s last funding round?
Beijing Sinotau International Pharmaceutical Technology Co., Ltd.'s most recent funding round was Growth Equity on December 1, 2024.
Who are the main investors in Beijing Sinotau International Pharmaceutical Technology Co., Ltd.?
Key investors in Beijing Sinotau International Pharmaceutical Technology Co., Ltd. include Centurium Capital, 中信金石投资有限公司, SDIC Venture Capital, Qiming Venture Partners, China Life Private Equity Investment Co., Ltd..
Will Beijing Sinotau International Pharmaceutical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Sinotau International Pharmaceutical Technology Co., Ltd..
How can I track Beijing Sinotau International Pharmaceutical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Beijing Sinotau International Pharmaceutical Technology Co., Ltd.'s shares on secondary markets.